$0.705
-0.016 (-2.33%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ESLA Prediction & Forecast by Similar Chart Analysis
Alphio's ESLA stock price prediction model matches the current Estrella Immunopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.71 (+0.28%). The 1-week path is $0.68 (-3.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Estrella Immunopharma Inc Stock?
Estrella Immunopharma Inc is not a good buy right now due to its poor financial performance and negative technical indicators. The current price is $0.71, which is down 49.27% year-to-date. The RSI is at 28.555, indicating that the stock is oversold, but this could also suggest a continued downtrend. The company has reported consistent losses, with a net income of -2,306,339 USD in Q2 2026 and a forward P/E ratio of 0, indicating no expected earnings growth. The main risk is the significant decline in stock value, as it has dropped 34.10% over the past year.
ESLA stock price ended at $0.71 on Friday, after losing -2.33%
Estrella Immunopharma Inc (ESLA) last closed at $0.7051, losing -2.33%. These facts feed the 1-day and 1-week ESLA price prediction above.
Forecast Drivers
Estrella Immunopharma Inc (ESLA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ESLA, ranked by similarity.
Seasonality analysis for ESLA
Historically the probability of a positive August return for ESLA is 33.33%. December offers the highest probability of a positive month at 93.02%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ESLA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.90 | $1.03 | $1.04 | +46.11% |
| Sep 2026 | $0.97 | $1.03 | $1.16 | +46.11% |
| Oct 2026 | $0.93 | $0.94 | $1.01 | +33.81% |
| Nov 2026 | $0.80 | $0.89 | $0.91 | +26.03% |
| Dec 2026 | $0.69 | $0.79 | $0.89 | +12.27% |
In 2026, Estrella Immunopharma Inc (ESLA) is projected to range from $0.69 to $1.16.
Estrella Immunopharma Inc 2026 monthly forecast
In Aug 2026, Estrella Immunopharma Inc is projected to average $1.03, with a low of $0.90 and high of $1.04.
In Sep 2026, Estrella Immunopharma Inc is projected to average $1.03, with a low of $0.97 and high of $1.16.
In Oct 2026, Estrella Immunopharma Inc is projected to average $0.94, with a low of $0.93 and high of $1.01.
In Nov 2026, Estrella Immunopharma Inc is projected to average $0.89, with a low of $0.80 and high of $0.91.
In Dec 2026, Estrella Immunopharma Inc is projected to average $0.79, with a low of $0.69 and high of $0.89.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.